17336 Federal Register / Vol. 76, No. 60 / Tuesday, March 29, 2011 / Rules and Regulations 

During the selection of these materials, 

consideration must also be given to 

ensure that the flammability 

characteristics of the materials will not 

be adversely affected by the use of 

cleaning agents and utensils used to 

remove cooking stains. 

b. Retain the surface materials of the 

existing galleys surrounding the 

cooktops per the airworthiness approval 

of the Boeing 747–2G4B model aircraft 

flammability requirements of Part I 

(§ 25.853 Amendment 25–59) of 

Appendix F of part 25. The use of the 

existing flammability approvals of the 

galley per the Type Certificate (A20WE) 

certification basis for the Boeing 747– 

2G4B model is acceptable as this 

modification consists of structural 

changes strictly to accommodate the 

installation of new cooktops. 

6. The cooktop must be ventilated 

with a system independent of the 

airplane cabin and cargo ventilation 

system. Procedures and time intervals 

must be established to inspect and clean 

or replace the ventilation system to 

prevent a fire hazard from the 

accumulation of flammable oils and be 

included in the instructions for 

continued airworthiness. The 

ventilation system ducting must be 

protected by a flame arrestor or an 

automatic shutoff valve in the overrange top ventilation system in lieu of 

the flame arrestor. [Note: The applicant 

may find additional useful information 

in Society of Automotive Engineers, 

Aerospace Recommended Practice 85, 

Rev. E, entitled ‘‘Air Conditioning 

Systems for Subsonic Airplanes,’’ dated 

August 1, 1991.] 

7. Means must be provided to contain 

spilled foods or fluids in a manner that 

will prevent the creation of a slipping 

hazard to occupants and will not lead to 

the loss of structural strength due to 

corrosion. 

8. Cooktop installations must provide 

adequate space for the user to 

immediately escape a hazardous 

cooktop condition. 

9. A means to shut off power to the 

cooktop must be provided at the galley 

containing the cooktop and in the 

cockpit. If additional switches are 

introduced in the cockpit, revisions to 

smoke or fire emergency procedures of 

the AFM will be required. 

Issued in Renton, Washington, on March 

22, 2011. 

K.C. Yanamura, 

Assistant Manager, Transport Airplane 

Directorate, Aircraft Certification Service. 

[FR Doc. 2011–7343 Filed 3–28–11; 8:45 am] 

BILLING CODE 4910–13–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

21 CFR Parts 520, 522, 526, and 529 

[Docket No. FDA–2011–N–0003] 

New Animal Drugs; Amikacin Sulfate, 

Ampicillin Trihydrate, Ceftiofur 

Hydrochloride, Cephapirin Benzathine, 

Chlortetracycline, Fenbendazole, 

Formalin, Furosemide, Glucose/ 

Glycine/Electrolyte, Pyrantel Pamoate, 

Sulfadimethoxine, Sulfamethazine, and 

Tetracycline 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Final rule; correcting 

amendments. 

SUMMARY: The Food and Drug 

Administration (FDA) is amending the 

animal drug regulations to reflect 

revised human food safety warnings or 

updated pathogen nomenclature on 

dosage form new animal drug product 

labeling that have not been codified. 

The regulations are also being amended 

to correct the wording of certain other 

conditions of use, to correct minor 

errors, and to revise some sections to 

reflect a current format. These actions 

are being taken to comply with the 

Federal Food, Drug, and Cosmetic Act 

(FD&C Act) and to improve the accuracy 

and readability of the regulations. 

DATES: This rule is effective March 29, 

2011. 

FOR FURTHER INFORMATION CONTACT: 

George K. Haibel, Center for Veterinary 

Medicine (HFV–6), Food and Drug 

Administration, 7519 Standish Pl., 

Rockville, MD 20855, 240–276–9019, 

e-mail: george.haibel@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: FDA has 

found that the animal drug regulations 

do not reflect certain human food safety 

warnings or the scientific nomenclature 

of pathogens that have been updated on 

labeling of various dosage form new 

animal drug products. At this time, the 

regulations are being amended to reflect 

approved labeling. The regulations are 

also being amended to correct the 

wording of certain other conditions of 

use and to correct minor errors. As the 

opportunity has presented itself, some 

sections have been revised to a current 

format. These actions are being taken to 

comply with the FD&C Act and to 

improve the accuracy and readability of 

the regulations. 

This rule does not meet the definition 

of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because 

it is a rule of ‘‘particular applicability.’’ 

Therefore, it is not subject to the 

congressional review requirements in 5 

U.S.C. 801–808. 

List of Subjects in 21 CFR Parts 520, 

522, 526, and 529 

Animal drugs. 

Therefore, under the Federal Food, 

Drug, and Cosmetic Act and under the 

authority delegated to the Commissioner 

of Food and Drugs and redelegated to 

the Center for Veterinary Medicine, 

21 CFR parts 520, 522, 526, and 529 are 

amended as follows: 

PART 520—ORAL DOSAGE FORM 

NEW ANIMAL DRUGS 

■ 1. The authority citation for 21 CFR 

part 520 continues to read as follows: 

Authority: 21 U.S.C. 360b. 

■ 2. In § 520.550, revise the section 

heading and paragraph (a), the first 

sentence in paragraph (c)(1), and 

paragraph (c)(3) to read as follows: 

§ 520.550 Glucose/glycine/electrolyte. 

(a) Specifications. The product is 

distributed in packets each of which 

contains the following ingredients: 

Sodium chloride 8.82 grams, potassium 

phosphate 4.20 grams, citric acid 

anhydrous 0.5 gram, potassium citrate 

0.12 gram, aminoacetic acid (glycine) 

6.36 grams, and glucose 44.0 grams. 

(c) * * * 

(1) Glucose/glycine/electrolyte is 

indicated for use in the control of 

dehydration associated with diarrhea 

(scours) in calves.* * * 

* * * * * 

(3) The product should not be used in 

animals with severe dehydration (down, 

comatose, or in a state of shock). Such 

animals need intravenous therapy. A 

veterinarian should be consulted in 

severely scouring calves. The product is 

not nutritionally complete if 

administered by itself for long periods 

of time. It should not be administered 

beyond the recommended treatment 

period without the addition of milk or 

milk replacer. 

■ 3. In § 520.905a, revise paragraphs 

(e)(2)(i), (e)(2)(iii), (e)(3)(i), and (e)(3)(iii) 

to read as follows: 

§ 520.905a Fenbendazole suspension. 

* * * * * 

(e) * * * 

(2) * * * 

(i) Amount. Administer orally 5 mg/ 

kg of body weight (2.3 mg/lb). 

Retreatment may be needed after 4 to 

6 weeks. 

* * * * * 

(iii) Limitations. Cattle must not be 

slaughtered within 8 days following last 

treatment. A withdrawal period has not 


wwoods2 on DSK1DXX6B1PROD with RULES_PART 1
Federal Register / Vol. 76, No. 60 / Tuesday, March 29, 2011 / Rules and Regulations 17337 

been established for this product in 

preruminating calves. Do not use in 

calves to be processed for veal. 

(3) * * * 

(i) Amount. Administer orally 10 mg/ 

kg of body weight (2.3 mg/lb). 

Retreatment may be needed after 4 to 6 

weeks. 

* * * * * 

(iii) Limitations. Cattle must not be 

slaughtered within 8 days following last 

treatment. A withdrawal period has not 

been established for this product in 

preruminating calves. Do not use in 

calves to be processed for veal. Federal 

law restricts this drug to use by or on 

the order of a licensed veterinarian. 

* * * * * 

■ 4. In § 520.905c, revise paragraph 

(e)(2)(iii) to read as follows: 

§ 520.905c Fenbendazole paste. 

* * * * * 

(e) * * * 

(2) * * * 

(iii) Limitations. Cattle must not be 

slaughtered within 8 days following last 

treatment. A withdrawal period has not 

been established for this product in 

preruminating calves. Do not use in 

calves to be processed for veal. 

■ 5. In § 520.1422, revise paragraph (b) 

to read as follows: 

§ 520.1422 Metoserpate hydrochloride. 

* * * * * 

(b) Sponsor. See No. 053501 in 

§ 510.600(c) of this chapter. 

* * * * * 

■ 6. In § 520.2043, revise paragraph 

(d)(1)(iii) to read as follows: 

§ 520.2043 Pyrantel pamoate suspension. 

* * * * * 

(d) * * * 

(1) * * * 

(iii) Limitations. Do not use in horses 

intended for human consumption. 

When the drug is for administration by 

stomach tube, it shall be labeled: 

‘‘Federal law restricts this drug to use by 

or on the order of a licensed 

veterinarian.’’ 

* * * * * 

■ 7. In § 520.2044, revise paragraph 

(d)(2) to read as follows: 

§ 520.2044 Pyrantel pamoate paste. 

* * * * * 

(d) * * * 

(2) Limitations. Do not use in horses 

intended for human consumption. 

■ 8. In § 520.2220a, revise paragraph 

(d)(3)(ii) to read as follows: 

§ 520.2220a Sulfadimethoxine oral 

solution and soluble powder. 

* * * * * 

(d) * * * 

(3) * * * 

(ii) Indications for use. For the 

treatment of shipping fever complex and 

bacterial pneumonia associated with 

Pasteurella spp. sensitive to 

sulfadimethoxine; and calf diphtheria 

and foot rot associated with 

Fusobacterium necrophorum 

(Sphaerophorus necrophorus) sensitive 

to sulfadimethoxine. 

* * * * * 

■ 9. In § 520.2220b, revise paragraph (d) 

to read as follows: 

§ 520.2220b Sulfadimethoxine tablets and 

boluses. 

* * * * * 

(d) Conditions of use—(1) Cattle—(i) 

Amount. Administer 2.5 grams per 100 

pounds body weight for 1 day followed 

by 1.25 grams per 100 pounds body 

weight per day; treat for 4 to 5 days. 

(ii) Indications for use. For the 

treatment of shipping fever complex and 

bacterial pneumonia associated with 

Pasteurella spp. sensitive to 

sulfadimethoxine; and calf diphtheria 

and foot rot associated with 

Fusobacterium necrophorum sensitive 

to sulfadimethoxine. 

(iii) Limitations. Do not administer 

within 7 days of slaughter; milk that has 

been taken from animals during 

treatment and 60 hours (5 milkings) 

after the latest treatment must not be 

used for food. A withdrawal period has 

not been established for this product in 

preruminating calves. Do not use in 

calves to be processed for veal. 

(2) Dogs and cats—(i) Amount. 

Administer 25 milligrams per pound of 

body weight on the first day followed by 

12.5 milligrams per pound of body 

weight per day until the animal is free 

of symptoms for 48 hours. 

(ii) Indications for use. Treatment of 

sulfadimethoxine-susceptible bacterial 

infections. 

(iii) Limitations. Federal law restricts 

this drug to use by or on the order of 

a licensed veterinarian. 

(3) Beef cattle and nonlactating dairy 

cattle—(i) Amount. Administer one 

12.5-gram-sustained-release bolus for 

the nearest 200 pounds of body weight, 

i.e., 62.5 milligrams per pound of body 

weight. Do not repeat treatment for 7 

days. 

(ii) Indications for use. Treatment of 

shipping fever complex and bacterial 

pneumonia associated with organisms 

such as Pasteurella spp. sensitive to 

sulfadimethoxine; calf diphtheria and 

foot rot associated with Fusobacterium 

necrophorum sensitive to 

sulfadimethoxine. 

(iii) Limitations. Do not use in female 

dairy cattle 20 months of age or older. 

Do not administer within 12 days of 

slaughter. Federal law restricts this drug 

to use by or on the order of a licensed 

veterinarian. 

■ 10. In § 520.2260a, revise paragraph 

(a)(3)(iii) to read as follows: 

§ 520.2260a Sulfamethazine oblet, tablet, 

and bolus. 

(a) * * * 

(3) * * * 

(iii) Limitations. Administer daily 

until animal’s temperature and 

appearance are normal. If symptoms 

persist after using for 2 or 3 days consult 

a veterinarian. Fluid intake must be 

adequate. Treatment should continue 

24 to 48 hours beyond the remission of 

disease symptoms, but not to exceed 

5 consecutive days. Follow dosages 

carefully. Do not treat cattle within 

10 days of slaughter. Do not use in 

female dairy cattle 20 months of age or 

older. Use of sulfamethazine in this 

class of cattle may cause milk residues. 

A withdrawal period has not been 

established in preruminating calves. Do 

not use in calves to be processed for 

veal. Do not use in horses intended for 

human consumption. 

* * * * * 

■ 11. In § 520.2261a, revise the section 

heading; the first sentence in paragraph 

(c)(2)(iii); and paragraph (c)(3) to read as 

follows: 

§ 520.2261a Sulfamethazine solution. 

* * * * * 

(c) * * * 

(2) * * * 

(iii) Chickens and turkeys. In chickens 

for control of infectious coryza 

(Avibacterium paragallinarum), 

coccidiosis (Eimeria tenella, Eimeria 

necatrix), acute fowl cholera 

(Pasteurella multocida), and pullorum 

disease (Salmonella pullorum). * * * 

(3) Limitations. Add the required dose 

to that amount of water that will be 

consumed in 1 day. Consumption 

should be carefully checked. Have only 

medicated water available during 

treatment. Withdraw medication from 

cattle, chickens, and turkeys 10 days 

prior to slaughter for food. Withdraw 

medication from swine 15 days before 

slaughter for food. Do not medicate 

chickens or turkeys producing eggs for 

human consumption. Treatment of all 

diseases should be instituted early. 

Treatment should continue 24 to 48 

hours beyond the remission of disease 

symptoms, but not to exceed a total of 

5 consecutive days in cattle or swine. 

Medicated cattle, swine, chickens, and 

turkeys must actually consume enough 

medicated water which provides the 

recommended dosages. Do not use in 

female dairy cattle 20 months of age or 


wwoods2 on DSK1DXX6B1PROD with RULES_PART 1
17338 Federal Register / Vol. 76, No. 60 / Tuesday, March 29, 2011 / Rules and Regulations 

older. Use of sulfamethazine in this 

class of cattle may cause milk residues. 

A withdrawal period has not been 

established in preruminating calves. Do 

not use in calves to be processed for 

veal. 

* * * * * 

■ 12. In § 520.2261b, revise paragraph 

(d)(1)(ii) and paragraph (d)(4)(iii) to read 

as follows: 

§ 520.2261b Sulfamethazine powder. 

* * * * * 

(d) * * * 

(1) * * * 

(ii) Indications for use. For control of 

infectious coryza (Avibacterium 

paragallinarum), coccidiosis (Eimeria 

tenella, E. necatrix), acute fowl cholera 

(Pasteurella multocida), and pullorum 

disease (Salmonella pullorum). 

* * * * * 

(4) * * * 

(iii) Limitations. Add the required 

dose to that amount of water that will 

be consumed in 1 day. Consumption 

should be carefully checked. Have only 

medicated water available during 

treatment. Withdraw medication from 

cattle 10 days prior to slaughter for food. 

Treatment of all diseases should be 

instituted early. Treatment should 

continue 24 to 48 hours beyond the 

remission of disease symptoms, but not 

to exceed a total of 5 consecutive days. 

Medicated cattle must actually consume 

enough medicated water which 

provides the recommended dosages. Do 

not use in female dairy cattle 20 months 

of age or older. Use of sulfamethazine in 

this class of cattle may cause milk 

residues. A withdrawal period has not 

been established in preruminating 

calves. Do not use in calves to be 

processed for veal. 

■ 13. In § 520.2345d, revise paragraph 

(b)(2), the first sentence in paragraph 

(d)(1)(iii), and paragraph (d)(2)(iii) to 

read as follows: 

§ 520.2345d Tetracycline powder. 

* * * * * 

(b) * * * 

(2) No. 000010: 25, 102.4, and 324 

grams per pound as in paragraph (d) of 

this section. 

* * * * * 

(d) * * * 

(1) * * * 

(iii) Limitations. Administer for 3 to 5 

days; do not slaughter animals for food 

within 4 days of treatment for No. 

000010 and within 5 days of treatment 

for Nos. 046573, 054925, 057561, 

059130, and 061623; prepare a fresh 

solution daily; use as the sole source of 

tetracycline. * * * 

(2) * * * 

(iii) Limitations. Administer for 3 to 5 

days; do not slaughter animals for food 

within 7 days of treatment for No. 

000010 and within 4 days of treatment 

for Nos. 046573, 054925, 057561, 

059130, and 061623; prepare a fresh 

solution daily; use as the sole source of 

tetracycline. 

* * * * * 

PART 522—IMPLANTATION OR 

INJECTABLE DOSAGE FORM NEW 

ANIMAL DRUGS 

■ 14. The authority citation for 21 CFR 

part 522 continues to read as follows: 

Authority: 21 U.S.C. 360b. 

■ 15. Revise § 522.56 to read as follows: 

§ 522.56 Amikacin. 

(a) Specifications. Each milliliter of 

solution contains 50 milligrams (mg) of 

amikacin as amikacin sulfate. 

(b) Sponsors. See Nos. 000856 and 

059130 in § 510.600(c) of this chapter. 

(c) Conditions of use in dogs—(1) 

Amount. 5 mg/pound (lb) of body 

weight twice daily by intramuscular or 

subcutaneous injection. 

(2) Indications for use. For treatment 

of genitourinary tract infections 

(cystitis) caused by susceptible strains 

of Escherichia coli and Proteus spp. and 

skin and soft tissue infections caused by 

susceptible strains of Pseudomonas spp. 

and E. coli. 

(3) Limitations. Do not use in horses 

intended for human consumption. 

Federal law restricts this drug to use by 

or on the order of a licensed 

veterinarian. 

■ 16. In § 522.90b, revise the section 

heading and paragraphs (a), (b), and (d) 

to read as follows: 

§ 522.90b Ampicillin trihydrate. 

(a) Specifications. Each milliliter of 

aqueous suspension constituted from 

ampicillin trihydrate powder contains 

50, 100, or 250 milligrams (mg) 

ampicillin equivalents. 

(b) Sponsors. See Nos. 000010 and 

010515 in § 510.600(c) of this chapter. 

* * * * * 

(d) Conditions of use—(1) Dogs and 

cats—(i) Amount. 3 mg/pound (lb) of 

body weight twice daily by 

subcutaneous or intramuscular 

injection. 

(ii) Indications for use. For treatment 

of strains of organisms susceptible to 

ampicillin and associated with 

respiratory tract infections, urinary tract 

infections, gastrointestinal infections, 

skin infections, soft tissue infections, 

and postsurgical infections. 

(iii) Limitations. Federal law restricts 

this drug to use by or on the order of 

a licensed veterinarian. 

(2) Cattle—(i) Amount. 2 to 5 mg/lb of 

body weight once daily by 

intramuscular injection. 

(ii) Indications for use. For treatment 

of respiratory tract infections caused by 

organisms susceptible to ampicillin, 

bacterial pneumonia (shipping fever, 

calf pneumonia, and bovine pneumonia) 

caused by Aerobacter spp., Klebsiella 

spp., Staphylococcus spp., 

Streptococcus spp., Pasteurella 

multocida, and Escherichia coli. 

(iii) Limitations. Do not treat cattle for 

more than 7 days. Milk from treated 

cows must not be used for food during 

treatment or for 48 hours (4 milkings) 

after the last treatment. Cattle must not 

be slaughtered for food during treatment 

or for 144 hours (6 days) after the last 

treatment. Federal law restricts this drug 

to use by or on the order of a licensed 

veterinarian. 

■ 17. In § 522.313b, revise paragraph (a) 

to read as follows: 

§ 522.313b Ceftiofur hydrochloride. 

(a) Specifications. Each milliliter of 

ceftiofur hydrochloride suspension 

contains 50 milligrams (mg) ceftiofur 

equivalents. 

* * * * * 

■ 18. In § 522.1010, redesignate 

paragraph (d)(3)(iii) as paragraph 

(d)(2)(iii); and add new paragraph 

(d)(3)(iii) to read as follows: 

§ 522.1010 Furosemide. 

* * * * * 

(d) * * * 

(3) * * * 

(iii) Limitations. Treatment not to 

exceed 48 hours post-parturition. Milk 

taken during treatment and for 48 hours 

(four milkings) after the last treatment 

must not be used for food. Cattle must 

not be slaughtered for food within 48 

hours following last treatment. 

PART 526—INTRAMAMMARY DOSAGE 

FORM NEW ANIMAL DRUGS 

■ 19. The authority citation for 21 CFR 

part 526 continues to read as follows: 

Authority: 21 U.S.C. 360b. 

■ 20. In § 526.363, revise paragraph 

(d)(1) and the first sentence in 

paragraph (d)(3) to read as follows: 

§ 526.363 Cephapirin benzathine. 

* * * * * 

(d) * * * 

(1) Amount. Infuse the contents of one 

syringe into each quarter. 

* * * * * 

(3) Limitations. Infuse each quarter 

following last milking, but no later than 

30 days before calving. * * * 


wwoods2 on DSK1DXX6B1PROD with RULES_PART 1
Federal Register / Vol. 76, No. 60 / Tuesday, March 29, 2011 / Rules and Regulations 17339 

PART 529—CERTAIN OTHER DOSAGE 

FORM NEW ANIMAL DRUGS 

■ 21. The authority citation for 21 CFR 

part 529 continues to read as follows: 

Authority: 21 U.S.C. 360b. 

§ 529.50 [Redesignated as § 529.56 and 

Amended] 

■ 22. Redesignate § 529.50 as § 529.56 

and revise it to read as follows: 

§ 529.56 Amikacin. 

(a) Specifications. Each milliliter (mL) 

of solution contains 250 milligrams of 

amikacin as amikacin sulfate. 

(b) Sponsors. See Nos. 000856 and 

059130 in § 510.600(c) of this chapter. 

(c) Conditions of use in horses—(1) 

Amount. Administer 2 grams (8 mL) 

diluted with 200 mL of sterile 

physiological saline by intrauterine 

infusion daily for 3 consecutive days. 

(2) Indications for use. For treating 

genital tract infections (endometritis, 

metritis, and pyometra) in mares caused 

by susceptible organisms including 

Escherichia coli, Pseudomonas spp., 

and Klebsiella spp. 

(3) Limitations. Do not use in horses 

intended for human consumption. 

Federal law restricts this drug to use by 

or on the order of a licensed 

veterinarian. 

■ 23. In § 529.1030, revise paragraphs 

(d)(1)(i) and (d)(1)(iv) to read as follows: 

§ 529.1030 Formalin. 

* * * * * 

(d) * * * 

(1) * * * 

(i) Select finfish. For control of 

external protozoa Ichthyophthirius spp., 

Chilodonella spp., Ichthyobodo spp., 

Ambiphrya spp., Epistylis spp., and 

Trichodina spp., and monogenetic 

trematodes Cleidodiscus spp., 

Gyrodactylus spp., and Dactylogyrus 

spp., on salmon, trout, catfish, 

largemouth bass, and bluegill. 

* * * * * 

(iv) All finfish. For control of external 

protozoa Ichthyophthirius spp., 

Chilodonella spp., Ichthyobodo spp., 

Ambiphrya spp., Epistylis spp., and 

Trichodina spp., and monogenetic 

trematodes Cleidodiscus spp., 

Gyrodactylus spp., and Dactylogyrus 

spp. 

* * * * * 

Dated: March 23, 2011. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2011–7313 Filed 3–28–11; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

33 CFR Part 100 

[Docket No. USCG–2009–0996] 

RIN 1625–AA08 

Special Local Regulation; Hydroplane 

Races Within the Captain of the Port 

Puget Sound Area of Responsibility 

AGENCY: Coast Guard, DHS. 

ACTION: Final rule. 

SUMMARY: The Coast Guard is 

establishing a special local regulation to 

restrict vessel movement in designated 

permanent hydroplane race areas in 

Dyes Inlet, Lake Washington and Lake 

Sammamish, WA during permitted 

hydroplane race events. When this 

special local regulation is activated, and 

thus subject to enforcement, this rule 

will limit the movement of nonparticipating vessels within the 

regulated race areas immediately prior 

to, during and immediately following 

the conclusion of permitted hydroplane 

marine events. This rule is needed to 

provide effective control over these 

events while ensuring the safety of the 

maritime public. 

DATES: This rule is effective March 29, 

2011. 

ADDRESSES: Comments and material 

received from the public, as well as 

documents mentioned in this preamble 

as being available in the docket, are part 

of docket USCG–2009–0996 and are 

available online by going to http:// 

www.regulations.gov, inserting USCG– 

2009–0996 in the ‘‘Keyword’’ box, and 

then clicking ‘‘Search.’’ This material is 

also available for inspection or copying 

at the Docket Management Facility (M– 

30), U.S. Department of Transportation, 

West Building Ground Floor, Room 

W12–140, 1200 New Jersey Avenue, SE., 

Washington, DC 20590, between 9 a.m. 

and 5 p.m., Monday through Friday, 

except Federal holidays. 

FOR FURTHER INFORMATION CONTACT: If 

you have questions on this rule, call or 

e-mail LTJG Ashley M. Wanzer, 

Waterways Management, Sector Puget 

Sound, Coast Guard; telephone 206– 

217–6175, e-mail 

SectorPugetSoundWWM@uscg.mil. If 

you have questions on viewing the 

docket, call Renee V. Wright, Program 

Manager, Docket Operations, telephone 

202–366–9826. 

SUPPLEMENTARY INFORMATION: 

Regulatory Information 

On Tuesday, January 19, 2010, we 

published a notice of proposed 

rulemaking (NPRM) entitled Safety 

Zone Regulation; Hydroplane Races 

within the Captain of the Port Puget 

Sound Area of Responsibility in the 

Federal Register (75 FR 2833). On 

Wednesday, January 19, 2011, we 

published a supplemental notice of 

proposed rulemaking (SNPRM), revising 

the rulemaking to create a special local 

regulation designating three permanent 

hydroplane race areas under 33 CFR 

part 100 in the Federal Register (76 FR 

3057). We did not receive any 

comments on the NPRM or SNPRM and 

did not receive any requests for a public 

meeting. A public meeting was not held. 

Under 5 U.S.C. 553(d)(3), the Coast 

Guard finds that good cause exists for 

making this rule effective less than 30 

days after publication in the Federal 

Register. Immediate action is necessary 

to protect life, property and the 

environment; therefore, a 30-day notice 

is impracticable. Delaying the effective 

date would be contrary to the intended 

objective of promoting safety during 

these permitted events because the 

ULHRA Spring Training takes place on 

21 April 2011 in the Lake Washington 

designated race area and this is less than 

30 days after publication in the Federal 

Register. 

Basis and Purpose 

The U.S. Coast Guard is establishing 

special local regulations to establish 

three permanent designated hydroplane 

race areas in Dyes Inlet, Lake 

Washington, and Lake Sammamish, WA 

within the Captain of the Port, Puget 

Sound Area of Responsibility. This 

action is necessary in order to restrict 

vessel movement in the vicinity of the 

race courses thereby promoting safety 

on navigable waters during these events. 

Background 

The Coast Guard receives numerous 

marine event permits for hydroplane 

races taking place on the waterways of 

Dyes Inlet, Lake Washington, and Lake 

Sammamish, WA. This rule establishes 

a special local regulation to restrict 

vessel movement in designated 

hydroplane race areas during permitted 

hydroplane marine events. This rule 

enables event sponsors and the Coast 

Guard to adequately provide safety in 

support of these marine events. 

Initial Enforcement 

The Coast Guard will enforce the 

special local regulation for Lake 

Washington in 33 CFR 100.1308 from 

10 a.m. until 4 p.m. on April 21, 2011. 


wwoods2 on DSK1DXX6B1PROD with RULES_PART 1